From: Interim data monitoring to enroll higher-risk participants in HIV prevention trials
Prevalence/characteristic | Apapa | Ikeja | Central | Peripheral |
---|---|---|---|---|
HIV prevalence (%, 95% CI)* | 20.1 (17.2, 23.2) | 8.7 (6.5, 11.4) | 14.3 (11.9, 16.9) | 17.3 (13.8, 21.3) |
Gonorrhea prevalence (%, 95% CI)* | 14.9 (12.2, 18.0) | 6.7 (4.6, 9.4) | 3.4 (2.2, 5.0) | 5.5 (3.5, 8.2) |
Chlamydia prevalence (%, 95% CI)* | 5.4 (3.7, 7.5) | 5.3 (3.4, 7.7) | 2.9 (1.8, 4.3) | 2.2 (1.0, 4.2) |
Average number of coital acts in last week | 3.9 | 2.8 | 7.1 | 5.6 |
Average number of new partners in last month | 1.8 | 0.4 | 8.2 | 5.1 |
Proportion of coital acts protected by condom in last week (%) | 66.7 | 52.0 | 55.2 | 59.3 |